Parameswaran N Hari

Parameswaran N Hari

UNVERIFIED PROFILE

Are you Parameswaran N Hari?   Register this Author

Register author
Parameswaran N Hari

Parameswaran N Hari

Publications by authors named "Parameswaran N Hari"

Are you Parameswaran N Hari?   Register this Author

56Publications

2026Reads

6Profile Views

Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Aug 6;25(8):1689-1694. Epub 2019 Apr 6.

Blood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.04.003DOI Listing
August 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Haematologica 2019 Apr 31;104(4):844-854. Epub 2018 Oct 31.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.200121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442962PMC
April 2019

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Biol Blood Marrow Transplant 2019 04 10;25(4):699-711. Epub 2018 Nov 10.

Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453753PMC
April 2019

Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2018 05 2;24(5):983-988. Epub 2018 Feb 2.

Division of Hematology, Oncology & Transplantation, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.015DOI Listing
May 2018

Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.

Am J Hematol 2017 Oct 29;92(10):E610-E611. Epub 2017 Jul 29.

Medical College of Wisconsin, Blood and Marrow Transplant Program, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24850DOI Listing
October 2017

Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.

Clin Lymphoma Myeloma Leuk 2017 07 12;17(7):408-414. Epub 2017 May 12.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.05.005DOI Listing
July 2017

Instrumental variable with competing risk model.

Stat Med 2017 04 8;36(8):1240-1255. Epub 2017 Jan 8.

Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.7205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479873PMC
April 2017

Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validity.

Leuk Lymphoma 2016 12 22;57(12):2827-2832. Epub 2016 Apr 22.

c Division of Hematology , Mayo Clinic College of Medicine , Rochester , MN , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.3109/10428194.2016.1
Publisher Site
http://dx.doi.org/10.3109/10428194.2016.1170828DOI Listing
December 2016

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Ibrutinib in Refractory Classic Hodgkin's Lymphoma.

N Engl J Med 2015 Oct;373(14):1381-2

Medical College of Wisconsin, Milwaukee, WI

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1505857DOI Listing
October 2015

Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas.

World J Transplant 2015 Sep;5(3):81-8

Narendranath Epperla, Timothy S Fenske, Parameswaran N Hari, Mehdi Hamadani, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI 53226,United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5500/wjt.v5.i3.81DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580930PMC
September 2015

Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma.

Biol Blood Marrow Transplant 2015 Apr 30;21(4):701-6. Epub 2014 Dec 30.

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.12.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361014PMC
April 2015

Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of age.

Expert Rev Hematol 2014 Jun 2;7(3):321-4. Epub 2014 May 2.

Hematologic Malignancies Program, Division of Hematology/Oncology, Medical College of Wisconsin, Froedtert Hospital, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.913978DOI Listing
June 2014

Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.

World J Stem Cells 2014 Apr;6(2):69-81

Abraham S Kanate, Osborn Hematopoietic Malignancy and Transplantation program, Section of Hematology/Oncology, West Virginia University, Morgantown, WV 26506, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4252/wjsc.v6.i2.69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999783PMC
April 2014

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.

Biol Blood Marrow Transplant 2013 Dec 3;19(12):1740-4. Epub 2013 Oct 3.

Division of Blood and Marrow Transplant, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.09.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906436PMC
December 2013

Multiple myeloma: future directions in autologous transplantation and novel agents.

Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S20-5

Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin 53206, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.11.002DOI Listing
January 2013

Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report.

J Med Case Rep 2011 Oct 7;5:508. Epub 2011 Oct 7.

Division of Nephrology, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee WI 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-5-508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213680PMC
October 2011

Access to hematopoietic stem cell transplantation: effect of race and sex.

Cancer 2010 Jul;116(14):3469-76

Center for Nursing Research, School of Nursing, Medical College of Georgia, Augusta, Georgia 30912, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153958PMC
July 2010